A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Clinical trial NCT06647069 · RECRUITING

Trial details

NCT number: NCT06647069
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Rheumatoid Arthritis (RA)

Start date: 2025-03-27
Primary completion: 2029-06-25
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.